Europe - Euronext Milan - BIT:1LLY - US5324571083 - Common Stock
We assign a fundamental rating of 6 out of 10 to 1LLY. 1LLY was compared to 55 industry peers in the Pharmaceuticals industry. While 1LLY belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1LLY is valued quite expensively, but it does show have an excellent growth rating. These ratings could make 1LLY a good candidate for growth investing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROIC | 28.84% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 8.12 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.38 | ||
| Fwd PE | 30.78 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 149.77 | ||
| EV/EBITDA | 35.23 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.64% |
ChartMill assigns a fundamental rating of 6 / 10 to 1LLY.MI.
ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (1LLY.MI). This can be considered as Overvalued.
ELI LILLY & CO (1LLY.MI) has a profitability rating of 9 / 10.
The Earnings per Share (EPS) of ELI LILLY & CO (1LLY.MI) is expected to grow by 84.93% in the next year.
The dividend rating of ELI LILLY & CO (1LLY.MI) is 4 / 10 and the dividend payout ratio is 28.28%.